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Abstract
Background: Few data have been published on the association of variables of the insulin resistance
syndrome and serum total homocysteine (tHcy), a putative risk factor for cardiovascular morbidity,
in representative samples of total populations or in Hispanic Americans.
Methods: To describe the distributions of serum tHcy concentration and variables associated with
insulin resistance in Mexican American men and to assess their association, data from a cross-
sectional survey of a large national sample, the Third National Health and Nutrition Examination
Survey were analyzed. Analyses were restricted to Mexican American men aged 40–74 years with
data on glycated hemoglobin (%), body mass index (BMI), body fat distribution, HDL cholesterol,
fasting serum insulin, serum triglycerides and serum tHcy concentrations.
Results: Cumulative distributions of serum tHcy shifted to the right with increasing age. Log serum
tHcy was not associated with prevalence of diagnosed diabetes mellitus or glycated hemoglobin
percent or other risk factors other than age. Log serum tHcy concentration showed borderline
significant (p = 0.049) positive association with fasting serum insulin concentration independent of
age and BMI, only in men aged 60–74.
Conclusion: No consistent association of tHcy with diabetes prevalence or variables of the insulin
resistance syndrome were found in Mexican American men aged 40–74 years. Further research is
needed on the associations of serum tHcy concentration with insulin resistance and other
components of the insulin resistance syndrome in persons of varying ethnicity.
Introduction
A number of previous studies have yielded conflicting
results as to whether serum total homocysteine concentra-
tion (tHcy) is associated with diabetes mellitus or with
variables of the insulin resistance syndrome [1–15]. In
order to test the null hypothesis that type II diabetes and
variables comprising the insulin resistance syndrome are
not significantly associated with tHcy concentration
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independent of ethnicity, and age, data from the Third
National Health and Nutrition Examination Survey
(NHANES III) were examined. Mexican Americans were
selected for study because of the reported higher preva-
lence of diabetes, insulin resistance and obesity compared
to non-Hispanic whites or blacks [16,17]. Levels of tHcy
were lower in Mexican Americans than in non-Hispanic
whites in NHANES III [9,18]. The study was restricted to
men to eliminate the possibility of confounding by gen-
der, pregnancy, menopause, parity or female hormone
use [19]. The study was restricted to persons older than 40
and younger than 75 years because that was the sub-sam-
ple that had an oral glucose tolerance test in NHANES III.
Methods
The Third National Health and Nutrition Examination
Survey (NHANES III) was conducted in 1988–1994 on a
nationwide multi-stage probability sample of approxi-
mately 40,000 persons from the civilian, non-institution-
alized population aged 2 months and over of the United
States excluding reservation lands of American Indians. Of
these, 31,311 were examined. Serum tHcy was measured
only in the second half of the survey (Phase II), itself a rep-
resentative sample of the U.S. population. The analyses of
serum tHcy concentration in this report are restricted to
560 Mexican American men aged 40–74 years examined
with valid serum tHcy and data on history of doctor diag-
nosed diabetes measured in the survey. The analyses of
serum tHcy and fasting serum insulin are restricted to 186
men examined in the morning after fasting 9 to 24 hours
with valid serum tHcy and insulin data, no history of dia-
betes, and not taking insulin or oral hypoglycemic agents.
Numbers of persons in various correlation and regression
analyses that follow may vary slightly due to differing
numbers with missing values on selected other variables.
Details of the plan, sampling, operation and response
have been published as have procedures used to obtain
informed consent and to maintain confidentiality of
information obtained [20,21].
Demographic data, medical history including doctor-
diagnosed diabetes mellitus, and behavioral information
was collected prior to the examination by household
interview. US Office of Management and Budget race cat-
egories and Mexican American ethnicity were determined
by self report [20]. Examinations were carried out in a
mobile examination center. Blood samples were obtained
at the examination center. Blood in a red-top Vacutainer
tube was allowed to stand for 45 min at room temperature
to allow complete clotting and clot retraction. Samples
were centrifuged at 1500 × g for 30 min at 4 degrees Cel-
sius. Samples were frozen at -20 degrees Celsius. Vitamin
B12 and folate in serum and folate in red blood cells were
measured by the Division of Environmental Health Labo-
ratory Sciences, National Center for Environmental
Health, Centers for Disease Control and Prevention, using
the Quantaphase II Folate/B12 radioassay kit (Bio-Rad
Laboratories, Hercules, CA) [22,23]. Surplus serum sam-
ples were stored at -70 degrees for 8–36 months before
analysis for total homocysteine concentration at the the
US Department of Agriculture Human Nutrition Research
Center on Aging, Tufts University using the reverse-phase
high-performance liquid chromatography (HPLC) and
fluorescence detection method of Araki and Sato
[22,24,25]. This assay measures total homocysteine,
including both reduced and oxidized forms. Quality con-
trol methods are described elsewhere [22]. Previous anal-
yses have shown that length of time fasting did not affect
tHcy concentration in this sample [25]. Values for tHcy
were missing if examined persons had no blood sample
obtained or if insufficient surplus serum was available.
Frozen serum was sent to The Missouri Diabetes Diagnos-
tic Laboratory and stored at -70 C until analysis for serum
insulin concentration. Insulin radioimmunoassay (RIA)
was performed using the Pharmacia Insulin RIA kit (Phar-
macia Diagnostics AB, Uppsala, Sweden) for the majority
of samples. (Prior to November, 1990, RIA kits purchased
from Cambridge Laboratories, Cambridge, Massachusetts
and its successor Ventrex, Inc., Cambridge, Massachusetts
were used. Based on simultaneous analyses using all three
assays, results from these kits were converted to Pharma-
cia equivalence.) Quality control procedures included the
reanalysis of 5% of specimens randomly selected either
within-assay or between assay and the analysis of batch
specimens consisting of four levels of control pools before
and after all survey specimens. The internal reference
range for fasting serum insulin in non-obese, nondiabetic
adults (mean age 28.1 years) was 3.08–11.92 uIU/mL
[22]. The cross-reactivity of Pharmacia insulin antibody
with proinsulin is approximately 40%. Concentration of
C-peptide in serum was determined using RIA in a 3-day,
batch, sequential-saturation method with two incuba-
tions [22]. The internal reference range for fasting serum
C-peptide was 0.266–1.079 pmol/mL. Frozen plasma was
sent to the Missouri Diabetes Diagnostic Laboratory for
determination of plasma glucose using a modified hex-
okinase enzymatic method on the Cobas Mira Chemistry
System (Roche Diagnostic Systems, Inc, Montclair, New
Jersey). Within and between-assay quality control proce-
dures were used. During the 6 years of the survey the coef-
ficient of variation of the method was 1.6–3.7% [22].
Glycated hemoglobin (HbA1c) in whole blood was deter-
mined using a high-performance liquid chromatographic
assay on the Diamat automated HPLC system, model 723
(Bio-Rad Laboratories, Hercules, CA). The upper limit of
normal for HbA1c in this system has been defined as 6.1%
[26].Nutrition Journal 2003, 2 http://www.nutritionj.com/content/2/1/6
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Technicians measured height to the nearest 0.1 centime-
ter, weight to the nearest 0.01 kg, triceps, subscapular,
suprailiac and mid-thigh skinfold thickness to the nearest
0.1 millimeter and waist and buttocks circumference to
the nearest 0.1 centimeter as described in detail elsewhere
[20,27,28]. With the sample person standing at minimal
respiration, waist circumference was measured in a hori-
zontal plane at the level of the high point of the iliac crest
to the nearest 0.1 cm. Hip circumference was measured in
a horizontal plane at the maximum extension of the but-
tocks. The following were computed: waist-to-hip circum-
ference ratio (WHR), and body mass index (BMI = weight
/height2, kg/m2). Extensive descriptive data on diabetes,
glucose tolerance, height, weight, BMI and obesity preva-
lence as well as serum tHcy, folate, and vitamin B12 in the
NHANES III population have been published elsewhere
and will not be duplicated here [9,18,19,21,23,25,28].
Statistical analysis
The plan of the present analyses was as follows. Detailed
descriptive statistics and measures of association were
computed initially using the Statistical Analysis System
(SAS) [29]. Pearson partial correlation was used to assess
the association of the natural logarithm (LN) of serum
tHcy concentration with other variables controlling for
age or age and BMI [29]. Correlation analysis results are
presented because of their familiarity, ease of interpreta-
tion by a wide audience, and use in previous reports that
may be compared to the present one. Multivariate logistic
regression analysis was used to estimate models for con-
trolling for confounding of the association of LN serum
tHcy with history of doctor-diagnosed diabetes mellitus
[29]. Linear multivariate regression analysis was used to
estimate models for controlling for confounding of the
association of LN serum tHcy with fasting serum insulin
[29]. Only variables with pre-specified hypotheses were
entered into the regression models. Following these pre-
liminary analyses, analyses were performed using tech-
niques that incorporated sampling weights and design
features of the survey [29,30]. Population estimates for
means and percentiles of variables were produced using
weighted SAS or SUDAAN procedures [31]. Pearson corre-
lations of LN serum tHcy with other variables were per-
formed using SAS weighted analysis and all statistical
testing and variance estimation were performed using the
PROC LOGISTIC and PROC REGRESS procedure for
regression models in the SUDAAN system [23,24].
Results
Figure 1 shows the distribution of serum tHcy concentra-
tion by age. As reported previously, the distributions show
rising levels in each decade of life from the fifth through
seventh decades. Perhaps due to smaller sample size and
increased variability, no further increase was apparent in
men aged 70–74. LN serum tHcy was correlated with age
overall (r = 0.26) but not within decades with the excep-
tion of the sixth (r = 0.26). The distribution of HbA1c var-
ied little with age (not shown). The cumulative
distribution of fasting serum insulin concentration
showed little variation with age until the seventh decade
(not shown). Blood pressure showed a consistent, graded
change with increasing age.
Mean natural log (LN) tHcy was computed in cases with a
history of doctor-diagnosed diabetes and in controls with
no such history. No relationship was found between
mean natural log (LN) tHcy and diabetic status before
(diabetes 2.27, no diabetes 2.26) or after (2.26, 2.31,
respectively) adjusting for age. Nor was age-specific quin-
tile of tHcy significantly associated with diabetic status.
However, mean LN serum folate was significantly higher
in diabetics after age adjustment (age-adjusted mean LN
folate diabetics 2.56, non-diabetics 2.42). In all men
within age groups, LN tHcy was not correlated with
HbA1c concentration (e.g. at age 60–69 r = -0.02). In a
weighted logistic regression analysis controlling for age
and BMI in men aged 40–74, LN tHCY was not signifi-
cantly associated with prevalent diabetes (beta coefficient
-1.018, SE 0.676, T -1.505, P = 0.146).
Within strata of age and overall, weighted correlation
coefficients were computed of LN serum tHcy concentra-
tion with variables associated with the insulin resistance
syndrome as well as vitamin levels. In combined fasting
and non-fasting Mexican American men with no history
of diabetes, LN tHcy was not associated with glycated
hemoglobin, HDL cholesterol, blood pressure, waist-to-
hip ratio, waist circumference, and body mass index. For
example for glycated hemoglobin correlation coefficients
by age were as follows: 40–49 y 0.14, 50–59 y -0.16, 60–
69 y 0.11, 70–74 y 0.04. LN serum tHcy was highly nega-
tively correlated with serum and red blood cell folate (e.g.
r = -0.48, -0.39, respectively at 40–49 years), and serum
vitamin B12 concentrations (e.g. r = -0.29 at 40–49 years).
Table 1 shows means by age of tHcy and other variables in
the subsample of fasting men. Blood pressure showed a
consistent, graded change with increasing age. In the sub-
set of fasting men aged 40–74 with no history of diabetes,
Pearson weighted correlation coefficients within strata of
age and in all men were computed for LN serum tHcy con-
centration with fasting blood measurements of insulin
resistance and glucose tolerance (Table 2). In partial cor-
relation analysis controlling for age in fasting men aged
40–74, LN tHcy not associated with fasting serum insulin,
C-peptide nor plasma glucose (e.g. for LN insulin r = -
0.004). Nor was tHcy correlated with values at two hours
post glucose load nor with serum triglycerides (r = 0.04).
Analyses within age strata are shown in Table 2.Nutrition Journal 2003, 2 http://www.nutritionj.com/content/2/1/6
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Cumulative distribution of serum total homocysteine in Mexican American men aged 40–74 years in the Third National Health  and Nutrition Examination Survey, 1988–1994 Figure 1
Cumulative distribution of serum total homocysteine in Mexican American men aged 40–74 years in the Third National Health 
and Nutrition Examination Survey, 1988–1994.
Table 1: Mean levels of serum tHcy and indicators of insulin resistance in fasting Mexican American men.
Variable 40–49 y 50–59 y 60–69 y 70–74 y
Fthcy, umol/L 9.1 9.2 10.8 11.3
FSI, pmol/L 76 77 77 60
FSG, mmol/L 5.9 6.0 5.9 5.5
FSCP, nmol/L 0.78 0.77 0.91 0.75
2 hr insulin, pmol/L 374 498 404 401
2 hr glucose, mmol/L 6.8 6.7 7.0 8.1
2 hr C-peptide, nmol/L 3.02 3.48 3.76 4.11
FTG, mmol/L 1.83 1.96 1.76 1.62
Age, yr 43 54 65 72
N 7 92 46 41 9
F, fasting; SI, serum insulin; SG, serum glucose; SCP, serum C-peptide; tHcy, total serum homocysteine; TG, serum triglyceride.
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A weighted linear regression model was fit with fasting
serum insulin concentration, the best measure in this sur-
vey of insulin resistance, as the dependent variable and LN
serum tHcy as the exposure variable controlling for age,
and BMI in the subset of fasting men aged 40–74 with no
history of diabetes. Serum tHcy was not associated with
fasting serum insulin (beta coefficient -6.217, SE 6.171, T
-1.007, P = 0.324). However an interaction of age and
tHcy was apparent and the analysis was repeated for men
40–59 and 60–74. No significant association was seen at
age 40–59 (beta coefficient -0.101, SE 0.141, T -0.717, P =
0.481. However at age 60–74 a borderline significant pos-
itive association was seen (beta coefficient 0.205, SE
0.098, T 2.078, P = 0.049).
Discussion
Few studies have examined the relationship of total serum
homocysteine concentration and diabetes, increased
serum insulin concentration or insulin resistance, despite
the relationship postulated for all these variables with cor-
onary heart disease and atherosclerosis [1–6]. Some stud-
ies report higher tHcy in persons with type 2 or type 1
diabetes than in non-diabetics [7–9], while others do not
[10,11]. One small study of Dutch healthy volunteers
reported independent associations of tHcy with glucose
utilization measured using a hyperinsulinemic euglyc-
emic clamp, the best indicator of insulin resistance [12].
However, another somewhat larger study of tHcy and
insulin-mediated glucose disposal failed to find any asso-
ciation [13]. An Israeli study reported a negative correla-
tion of plasma tHcy and insulin levels [14]. Well
established are associations of metabolic risk factor clus-
tering with insulin sensitivity and hyperinsulinemia, the
insulin resistance syndrome [4–6,15].
Mechanisms for a putative association of tHcy with diabe-
tes mellitus or insulin resistance are unclear. Homo-
cysteine is elevated in severe diabetic nephropathy as in
other forms of chronic renal failure, perhaps due to
decreased glomerular filtration rate, and pre- and intrare-
nal factors [32,33]. Acute hyperinsulinemia during a
hyperinsulinemic-euglycemic glucose clamp seemed to
lower tHcy in normal controls but had little effect in Type
2 diabetic patients in a small study [34]. Folate, vitamins
B12 or B6 are not among micronutrients shown to affect
insulin sensitivity [35]. However, folate and vitamin B12
are inversely associated with tHcy in Type 2 diabetes and
tHcy is associated with cardiovascular disease in Type 2
diabetes [36]. A study of Dutch diabetics failed to show
clustering of tHcy with other risk factors of the insulin
resistance syndrome [36–39].
NHANES III was the first study to provide population-
based data on distributions of tHcy in Mexican Americans
[25,40]. Concentrations of tHCY in serum were lower in
Mexican Americans than in non-Hispanic whites or
blacks. As in these other groups, tHcy increased with age
and was higher in men than women in Mexican Ameri-
cans. However, no published data were found on associa-
tions of tHcy and cardiovascular risk factors of the insulin
resistance syndrome in Mexican Americans. In the total
NHANES III sample, tHcy was inversely associated with
education years, and serum folate and B12 concentrations
and directly associated with smoking, systolic blood pres-
sure, total serum cholesterol, and history of diabetes [9].
In a Norwegian population, similar associations were
reported in addition to finding an inverse association with
physical activity in leisure time and a direct association
with plasma triglyceride concentration [41]. In a Japanese
case control study, plasma tHcy levels were higher in Type
2 diabetes with macroangiopathy than in diabetics with-
out macroangiopathy or non-diabetic controls [10]. Lev-
els of tHcy also were higher in diabetics without
macroangiopathy than in non-diabetics, significantly so
in women. Another study failed to find elevated tHcy in
Type I diabetics without nephropathy [42]. A Dutch pop-
ulation-based study showed no significant variation in
tHcy among those with normal or impaired glucose toler-
Table 2: Correlation coefficients of LN serum tHcy with serum indicators of insulin resistance in fasting Mexican American men.
Variable 40–49 y 50–59 y 60–69 y 70–74 y
LNFSI -0.001 -0.144 0.133 0.236
FSI -0.018 -0.053 0.066 0.208
FSG 0.177 0.008 0.008 0.158
FSCP 0.10 0.006 0.256 0.016
2 hr insulin -0.07 -0.082 0.088 0.073
2 hr C-peptide -0.044 -0.092 0.238 0.077
Triglycerides 0.143 -0.175 -0.024 -0.199
Age 0.105 0.081 0.040 0.161
N 7 92 46 41 9
LN, natural log; FSI, fasting serum insulin; FSG, fasting serum glucose; FSCP, fasting C-peptide; tHcy, total serum homocysteine.Nutrition Journal 2003, 2 http://www.nutritionj.com/content/2/1/6
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ance or NIDDM [43]. However, tHcy was more strongly
associated with prevalent cardiovascular disease in per-
sons with Type 2 diabetes than in others. For unknown
reasons, in 22 pregnant Finnish women with pre-eclamp-
sia, tHcy was strongly correlated with insulin sensitivity (r
= -0.51, p = 0.02) and area under the curve of the first 10-
minute insulin levels (r = 0.62, p = 0.002) during the insu-
lin-sensitivity test; no such correlations were seen in 16
pregnant control women [44]. Many studies report the
strong association of tHcy with serum folate, and vitamin
B12 levels.
Limitations of the present study include possible bias aris-
ing from survey non-response and from missing values for
some variables. However these are unlikely to seriously
compromise the validity of the study [30,45–49]. Results
may not be generalizable to other ethnic groups.
Future research should include longitudinal studies of
insulin resistance syndrome and serum tHcy, and vitamin
levels in non-Hispanic white and black and Hispanic men
and women to determine temporal sequence of any rela-
tionship. Euglycemic clamp, minimal model or other
techniques for accurate measurement of insulin resistance
and specific insulin assays should be used to confirm
whether insulin resistance, fasting specific insulin and
proinsulin vary in their association with serum tHcy. Insu-
lin resistance and serum tHcy should be assessed jointly as
risk factors for development of noninvasively measured
atherosclerosis (e.g. carotid intima-medial thickness) in
non-insulin dependent diabetes and insulin dependent
diabetes.
In conclusion, in a national sample of Mexican American
men aged 40–74 years, serum tHcy was not associated
with prevalent diabetes mellitus, body fat distribution,
obesity or other variables of the insulin resistance syn-
drome. Serum folate concentration was higher in diabet-
ics than nondiabetics and was negatively associated with
serum tHcy. Fasting serum insulin concentrations also
showed no consistent associations with serum tHcy levels
overall or within age subgroups.
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